Drug intelligence / Profile preview

rupatifen fumarate

Development stage
Unknown
Lead developer
Fujian Mindong Rejuvenation Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Rupatifen fumarate is a small molecule dual antagonist of the histamine H1 receptor and the platelet-activating factor (PAF) receptor. Developed by Fujian Mindong Rejuvenation Pharmaceutical, it is currently in Phase 3 clinical development for the treatment of seasonal allergic rhinitis. The drug is designed to inhibit the inflammatory pathways associated with both the early-phase (histamine-mediated) and late-phase (PAF-mediated) allergic responses, which contribute to symptoms such as sneezing, nasal itching, and congestion. In clinical trials, it is typically administered as an oral capsule and has been evaluated in head-to-head studies against rupatadine fumarate, a structurally related antihistamine.

Other names
rupatifen
02

Targets

PTAFR (Platelet-activating factor receptor)HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on rupatifen fumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rupatifen fumarate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call